Helen Suk Lam

age ~71

from Berkeley, CA

Get Report

Also known as:

Helen Suk-Ching Lam
Helen Suk Ching Lam
Helen S Lam
Helen Suk Lamching
Helen P Leung
Helen Lamb

Phone and address:: 1531 Shattuck Ave, Berkeley, CA 94709
5108482888

Connected to:

Helen Lam Phones & Addresses

1531 Shattuck Ave, Berkeley, CA 94709 • 5108482888
1531 Shattuck Ave #303, Berkeley, CA 94709 • 5105274650 • 5108482888
2048 University Ave #2, Berkeley, CA 94704
921 Evelyn Ave, Albany, CA 94706
2036 Cypress Ave, San Pablo, CA 94806 • 5108482888
El Cerrito, CA
Poplarville, MS
Concord, CA
San Francisco, CA
Poplarville, MS
1531 Shattuck Ave APT 301, Berkeley, CA 94709 • 5108482888

Work

Position:

Production Occupations

Education

Degree:

Graduate or professional degree

Us Patents

Anti-Siglec-5 Antibodies And Methods Of Use Thereof
view source
US Patent:

20220315656, Oct 6, 2022
Filed:

May 9, 2022
Appl. No.:

17/740100
Inventors:

- South San Francisco CA, US
Helen LAM - Union City CA, US
Patricia CULP - Oakland CA, US
Arnon ROSENTHAL - Woodside CA, US
Assignee:

Alector LLC - South San Francisco CA
International Classification:

C07K 16/28
A61P 37/00
A61P 25/28
A61P 31/04
A61P 25/00
A61P 25/08
A61P 29/00
A61P 35/00
Abstract:

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Siglec-5 protein, e.g., human Siglec-5 or a mammalian Siglec-5, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-Cd33 Antibodies And Methods Of Use Thereof
view source
US Patent:

20220251190, Aug 11, 2022
Filed:

Aug 27, 2021
Appl. No.:

17/459835
Inventors:

- South San Francisco CA, US
Helen LAM - Union City CA, US
Seung-Joo LEE - San Francisco CA, US
William MONTEITH - San Francisco CA, US
Herve RHINN - San Francisco CA, US
Arnon ROSENTHAL - Woodside CA, US
Assignee:

Alector LLC - South San Francisco CA
International Classification:

C07K 16/28
A61P 35/00
A61K 39/395
C12N 15/85
Abstract:

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-Trem2 Antibodies And Methods Of Use Thereof
view source
US Patent:

20230107639, Apr 6, 2023
Filed:

Apr 21, 2022
Appl. No.:

17/726367
Inventors:

- South San Francisco CA, US
Tina SCHWABE - San Francisco CA, US
Ilaria TASSI - San Francisco CA, US
Helen LAM - Union City CA, US
Arnon ROSENTHAL - Woodside CA, US
Assignee:

Alector LLC - South San Francisco CA
International Classification:

C07K 16/28
Abstract:

The invention is generally directed to methods and compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a TREM2 protein, e.g., a mammalian TREM2 and/or human TREM2. The methods provided herein find use in preventing, reducing risk, or treating an individual having dementia, frontotemporal dementia, Alzheimer's disease, Nasu-Hakola disease, or multiple sclerosis.

Anti-Siglec-5 Antibodies And Methods Of Use Thereof
view source
US Patent:

20210395361, Dec 23, 2021
Filed:

Jul 26, 2019
Appl. No.:

17/263534
Inventors:

- South San Francisco CA, US
Rashmi BANKOTI - San Mateo CA, US
Helen LAM - Union City CA, US
Arnon ROSENTHAL - Woodside CA, US
Assignee:

Alector LLC - South San Francisco CA
International Classification:

C07K 16/28
A61K 47/68
A61P 35/00
Abstract:

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a Siglec-5 protein, e.g., human Siglec-5, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-Cd33 Antibodies And Methods Of Use Thereof
view source
US Patent:

20210317208, Oct 14, 2021
Filed:

Aug 30, 2019
Appl. No.:

17/272083
Inventors:

- South San Francisco CA, US
Helen LAM - Union City CA, US
Leonard G. PRESTA - Palo Alto CA, US
Arnon ROSENTHAL - Woodside CA, US
Assignee:

Alector LLC - South San Francisco CA
International Classification:

C07K 16/28
Abstract:

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a CD33 polypeptide, e.g., a mammalian CD33 or human CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-Siglec-7 Antibodies And Methods Of Use Thereof
view source
US Patent:

20210246204, Aug 12, 2021
Filed:

Jun 7, 2019
Appl. No.:

16/972840
Inventors:

- South San Francisco CA, US
Seung-Joo LEE - Benicia CA, US
Helen LAM - Union City CA, US
Arnon ROSENTHAL - Woodside CA, US
Assignee:

Alector LLC - South San Francisco CA
International Classification:

C07K 16/28
Abstract:

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a Siglec-7 protein, e.g., human Siglec-7 or a mammalian Siglec-7, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-Cd33 Antibodies And Methods Of Use Thereof
view source
US Patent:

20210139581, May 13, 2021
Filed:

May 7, 2020
Appl. No.:

16/869315
Inventors:

- South San Francisco CA, US
Helen LAM - Union City CA, US
Arnon ROSENTHAL - Woodside CA, US
Seung-Joo LEE - Benicia CA, US
Nels P. NIELSON - Hopkinton NH, US
Robert PEJCHAL - Norwich VT, US
Assignee:

ALECTOR LLC - South San Francisco CA
International Classification:

C07K 16/28
C07K 16/46
Abstract:

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-Siglec-5 Antibodies And Methods Of Use Thereof
view source
US Patent:

20210017275, Jan 21, 2021
Filed:

May 15, 2018
Appl. No.:

16/614302
Inventors:

- South San Francisco CA, US
Helen LAM - Union City CA, US
Patricia CULP - Oakland CA, US
Arnon ROSENTHAL - Woodside CA, US
Assignee:

Alector LLC - South San Francisco CA
International Classification:

C07K 16/28
A61P 37/00
A61P 25/00
A61P 25/28
A61P 25/08
A61P 31/04
A61P 29/00
A61P 35/00
Abstract:

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Siglec-5 protein, e.g., human Siglec-5 or a mammalian Siglec-5, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Name / Title

Company / Classification

Phones & Addresses

Helen Lam
President

Charity Tongs Foundation
Membership Organization

2179 28 Ave, San Francisco, CA 94116
4155668939

Helen Lam
President

TONGS CHARITY FOUNDATION

2179 28 Ave, San Francisco, CA 94116

Resumes

Helen Lam San Francisco, CA

view source

Work:

Cloth & Dagger
San Francisco, CA
2012 to 2013
Co-Founder MSA (Mine Safety Appliances)
Pittsburgh, PA
May 2011 to Aug 2011
Intern Plant Construction Company
San Francisco, CA
Dec 2006 to Jul 2010
Project Manager

Education:

Carnegie Mellon University
Pittsburgh, PA
2010 to 2011
MS in Product Development University of California, Berkeley
Berkeley, CA
2003 to 2007
BS in Civil Engineering

Skills:

SolidWorks, AutoCAD, MATLAB, Adobe Creative Suite, Rapid prototyping, Machine Shop, User Research

Helen Lam San Jose, CA

view source

Work:

Hoopla Software

Jun 2014 to 2000
Director Customer Success for sales motivation SaaS start-up BrightEdge Technologies, Inc
San Mateo, CA
Dec 2011 to Jun 2014
Director Client Services for corporate accounts Veracode, Inc
Silicon Valley, CA
Dec 2010 to Dec 2011
Sr. Customer Success Manager Promatch
Silicon Valley, CA
2010 to 2010
Volunteer as workshop Facilitator and Marketing Co-Lead YAHOO!, INC
Los Angeles, CA
2008 to 2009
Senior Manager, Yahoo! Network Quality for Ad Exchange INFOSYS TECHNOLOGY CONSULTING, INC
Los Angeles, CA
2004 to 2008
Senior Consultant A LA MODE FURNISHINGS, INC
Los Angeles, CA
2000 to 2002
COO PWC CONSULTING, LLP
New York, NY
1997 to 2000
Management Consultant - Marketing Strategy and Operation

Education:

Cornell University
Ithaca, NY
2004
MBA Wellesley College
Wellesley, MA
1997
BA